Apollo Hospitals Enterprise Ratios

Apollo Hospitals Enterprise Ltd Ratios

The Apollo Hospitals Enterprise Ltd Ratios page provides a complete fundamental analysis of Apollo Hospitals Enterprise Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Apollo Hospitals Enterprise Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Apollo Hospitals Enterprise Ltd (NSE: APOLLOHOSP, BSE: 508869) is currently trading at ₹7542.50, with a market capitalization of ₹1083.73B. As a major player in the Health services sector and Hospital/Nursing management industry, Apollo Hospitals Enterprise Ltd remains a key stock for fundamental analysis using Apollo Hospitals Enterprise Ltd Ratios.

Apollo Hospitals Enterprise Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Apollo Hospitals Enterprise Ltd P/E ratio currently stands at 65.85, making it one of the most tracked metrics in Apollo Hospitals Enterprise Ltd Ratios.

Historically, the Apollo Hospitals Enterprise Ltd P/E ratio has shown strong fluctuations:

• 2024: 65.85
• 2023: 101.64
• 2022: 75.65
• 2021: 61.52
• 2020: 270.20

The decline in Apollo Hospitals Enterprise Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Apollo Hospitals Enterprise Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 11.59.

Historical P/B trend:

• 2024: 11.59
• 2023: 13.17
• 2022: 10
• 2021: 11.55

Apollo Hospitals Enterprise Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Apollo Hospitals Enterprise Ltd P/S ratio currently stands at 4.37, an important part of Apollo Hospitals Enterprise Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 4.37
• 2023: 4.79
• 2022: 3.73
• 2021: 4.43

A stable or declining Apollo Hospitals Enterprise Ltd P/S ratio indicates cautious market sentiment.

Apollo Hospitals Enterprise Ltd Price to Cash Flow Ratio (P/CF)

The Apollo Hospitals Enterprise Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 49.37.

Historical Apollo Hospitals Enterprise Ltd Price to Cash Flow Ratio:

• 2024: 49.37
• 2023: 55.13
• 2022: 52.75
• 2021: 43.97
• 2020: 49.10

The declining Apollo Hospitals Enterprise Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Apollo Hospitals Enterprise Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Apollo Hospitals Enterprise Ltd EV currently stands at ₹1010B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 1010B
• 2023: 954.3B
• 2022: 655.61B
• 2021: 678.59B

Apollo Hospitals Enterprise Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Apollo Hospitals Enterprise Ltd EV/EBITDA ratio is currently 32.94, a key metric in Apollo Hospitals Enterprise Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 32.94
• 2023: 39.59
• 2022: 31.53
• 2021: 30.75

Stable Apollo Hospitals Enterprise Ltd EV/EBITDA indicates balanced valuation.

Apollo Hospitals Enterprise Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Apollo Hospitals Enterprise Ltd D/E ratio is currently 0.96, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.96
• 2023: 0.77
• 2022: 0.70
• 2021: 0.72

Apollo Hospitals Enterprise Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Apollo Hospitals Enterprise Ltd ROE currently stands at 19.09%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 19.09
• 2023: 13.68
• 2022: 13.86
• 2021: 20.65

Apollo Hospitals Enterprise Ltd maintains stable profitability levels.

Apollo Hospitals Enterprise Ltd Ratios Analysis Summary

The Apollo Hospitals Enterprise Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Apollo Hospitals Enterprise Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Apollo Hospitals Enterprise Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.